Have a personal or library account? Click to login

Can the HALP score predict survival in severe COVID-19 pneumonia?

Open Access
|Dec 2023

Figures & Tables

Evaluation of mortality with binary logistic regression analysis

p valueOR95% CI for OR
LowerUpper
LDH0.0151.0031.0011.005
CRP0.0021.0121.0051.020
HALP score0.0020.8830.8170.954

General characteristics of patients who received intensive care and survived or deceased

SurvivalNon-survivalP value
Patients, n5251
Gender n (%)Male30 (57.7)28 (54.9)0.203
Female22 (42.3)23 (45.1)
Age (years) median (min-max)65.40 (38–90)69.71 (27–93)0.960
Comorbidity n (%)Yes46 (52.8)41 (47.2)0.258
No6 (37.5)10 (62.5)
Number of comorbidity median (min-max)1(0–4)2(0–4)0.857
Mechanical ventilation n (%)NIMV45 (86.5)1 (2)< 0.001
IMV7 (13.5)50 (98)
HALP score median (min-max)9.35 (2.27–59.97)6.83 (1.45–17.80)0.015
Hemoglobin (g/dL) median (min-max)11,9 (8.2–15.2)12.24 (8.8–15.1)0.48
Albumin (µL) median (min-max)32.33 (13–41)30.18 (18–37)0.006
Lymphocytes (µL) median (min-max)875.12 (200–3900)574.51 (200–1700)0.002
Platelet (103/mm3) median (min-max)295 (97–673)282 (56–715)0.48
Ferritin (ng/mL) median (min-max)375.44 (5.4–1500)517.82 (57–1500)0.014
Fibrinogen (mg/dl) mean±SD.462.75±131.60522.02±144.660.032
D-dimer (ng/mL) median (min-max)3.01 (0.15–25)3.02 (0.15–33.02)0.88
CRP (mg/L) median (min-max)85.06 (2–228)127.14 (8–211)< 0.001
ALT (IU/L) median (min-max)25(6–197)25(7–122)0.739
AST (IU/L) median (min-max)33(9–194)38(10–133)0.395
LDH (U/L) median (min-max)406 (148–1575)540 (251–1005)0.001
Language: English
Page range: 182 - 187
Submitted on: Jan 4, 2023
Accepted on: Nov 13, 2023
Published on: Dec 31, 2023
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Mustafa Çolak, Serkan Uçkun, Hikmet Çoban, Nurhan Sarıoğlu, Fuat Erel, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.